Publications & Works

Publication Network
Articles 28
All (28)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (24)
Scopus (24)
TRDizin (2)
Other Publications (1)

1. Identification of nonsense variants in the ATM gene mimicking SCID phenotype: a brief report

Firtina S., Saritas M., Ng Y. Y., Nepesov S., Kiykim A., Bozkurt S., et al.
Immunologic Research , vol.73, no.1, 2025 (SCI-Expanded, Scopus)

2. Design, Synthesis, Biological Evaluation and Molecular Docking Studies of a New Series of Maleimide Derivatives

Eyilcim O., Gunay F., Ng Y. Y., Acan O. U., TURGUT Z., GÜNKARA Ö. T.
CHEMISTRYOPEN , vol.13, no.12, 2024 (SCI-Expanded, Scopus) Sustainable Development

3. Long-term immunological changes after corrective cardiac surgery

BİLGİÇ ELTAN S., Amirov R., Babayeva R., Altunbas M. Y., Karakurt T., CAN S., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.100, no.6, 2024 (SCI-Expanded, Scopus) Sustainable Development

4. Using embossing ice particulate method to prepare polyvinyl alcohol/ pullulan hydrogels with surface open pores loaded with microspheres for breast cancer treatment

Barer N., Tunc B., Yilmaz B., Ng Y. Y., Dalgic A. D.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , vol.92, 2024 (SCI-Expanded, Scopus)

5. Design and synthesis of novel 1,2,3,4-tetrazines as new anti-leukemia cancer agents

Eyilcim O., Gunay F., GÜNKARA Ö. T., Ng Y. Y., Ulucan O., Erden I.
CHEMICAL BIOLOGY & DRUG DESIGN , vol.102, no.5, pp.1186-1201, 2023 (SCI-Expanded, Scopus)

6. TNFRSF13B VARIANTS ACT AS MODIFIERS TO CLINICAL PHENOTYPES IN COMMON VARIABLE IMMUNE DEFICIENCY DISORDERS

Firtina S., YENENLER-KUTLU A., Işıkgil B., Yozlu M., CEPECI B. N., Yilmaz H., et al.
Sabiad , vol.6, no.3, pp.210-218, 2023 (TRDizin)

7. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls

Senturk G., Ng Y. Y., Eltan S. B., Baser D., Ogulur I., Altindirek D., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , vol.95, no.3, 2022 (SCI-Expanded, Scopus) Sustainable Development

8. Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina S., Ng Y. Y., HATIRNAZ NG Ö., Kiykim A., Ozek E. Y., Kara M., et al.
IMMUNOLOGIC RESEARCH , vol.70, no.1, pp.44-55, 2022 (SCI-Expanded, Scopus) Sustainable Development

9. Synthesis, molecular modeling, and biological evaluation of novel imatinib derivatives as anticancer agents

Gunay F., Balta S., Ng Y. Y., Ulucan O., TURGUT Z., GÜNKARA Ö. T.
TURKISH JOURNAL OF CHEMISTRY , vol.46, no.1, pp.86-144, 2021 (SCI-Expanded, Scopus) Sustainable Development

10. Mutational landscape of severe combined immunodeficiency patients from Turkey

Çekiç Ş., Ng Y. Y., Ng Ö., Kıykım A., Özen A. O., Özen A. O., et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS , vol.47, no.6, pp.529-538, 2020 (SCI-Expanded, Scopus) Sustainable Development

11. High TUBB2A expression in childhood T-ALL is correlated with the clinical outcome

Khodzhaev K., HATIRNAZ NG Ö., TUĞCU D., ERBİLGİN Y., Ng Y. Y., Celkan T., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , vol.42, no.5, pp.581-588, 2020 (SCI-Expanded, Scopus) Sustainable Development

12. Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S. B., Kebudi R., ALTINDİREK D., Kaya A., Erbilgin Y., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.40, no.6, pp.883-892, 2020 (SCI-Expanded, Scopus) Sustainable Development

13. Lymphocyte Subgroups and KREC Numbers in Common Variable Immunodeficiency: A Single Center Study

YAZ İ., ÇİÇEK B., Ng Y. Y., Cetinkaya P. G., OSKAY HALAÇLI S., TAN Ç., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.40, no.3, pp.494-502, 2020 (SCI-Expanded, Scopus) Sustainable Development

14. Tanısı Zor Tek Gen Hastalıklarında Hedefe Yönelik Yeni Nesil Dizileme Panel Tasarımı: Primer İmmün Yetersizlik Örneği

FIRTINA S., NG Y. Y., HATIRNAZ NG Ö., SAYİTOĞLU M.
Sabiad , vol.3, 2020 (TRDizin)

15. A Novel FOXN1 Variant Is Identified in Two Siblings with Nude Severe Combined Immunodeficiency

FIRTINA S., Cipe F., NG Y. Y., KIYKIM A., HATIRNAZ NG Ö., Sudutan T., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.2, pp.144-147, 2019 (SCI-Expanded, Scopus) Sustainable Development

16. Kronik Myeloid Lösemide BCR-ABL Füzyon Transkriptinin Eş Zamanlı PCR ile Kantitasyonu İçin Referans Plazmid Oluşturulması

NG Y. Y., Yılmaz Z. H., HATIRNAZ NG Ö., SAYİTOĞLU M.
EXPERIMED , vol.7, no.13, pp.93-100, 2017 (Peer-Reviewed Journal)

17. A novel pathogenic frameshift variant of CD3E gene in two T-B plus NK plus SCID patients from Turkey

Firtina S., Ng Y. Y., Ng Ö., Nepesov S., Yesilbas O., Kilercik M., et al.
IMMUNOGENETICS , vol.69, no.10, pp.653-659, 2017 (SCI-Expanded, Scopus) Sustainable Development

18. First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof Dr Işil Barlan in Turkey

NG Y. Y., SISKO S., HATIRNAZ NG O., CATAL S., SEVER KAYA D., FIRTINA S., et al.
TURKISH JOURNAL OF IMMUNOLOGY , vol.2, no.2, pp.47, 2015 (Scopus)

19. X-linked agammaglobulinemia in two siblings with a novel mutation in the BTK gene who presented with polyarticular juvenile idiopathic arthritis

Patiroglu T., Akar H. H., Gunduz Z., Sisko S., NG Y. Y.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.44, no.2, pp.168-170, 2015 (SCI-Expanded, Scopus) Sustainable Development

20. Th17 Differentiation in Hyper IgE Syndrome IL 17 Secretion and RORGAMMAt Expression

AKKOC T., OGULUR I., TEVETOGLU A., IZGI A., HATIRNAZ NG O., NG Y. Y., et al.
Journal of Marmara University Institute of Health Sciences , vol.3, no.1, pp.17-22, 2013 (Peer-Reviewed Journal)

21. Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Pike-Overzet K., Rodijk M., NG Y. Y., Baert M. R. M., Lagresle-Peyrou C., Schambach A., et al.
LEUKEMIA , vol.25, no.9, pp.1471-1483, 2011 (SCI-Expanded, Scopus) Sustainable Development

22. Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK

NG Y. Y., Baert M. R. M., Pike-Overzet K., Rodijk M., Brugman M. H., Schambach A., et al.
LEUKEMIA , vol.24, no.9, pp.1617-1630, 2010 (SCI-Expanded, Scopus) Sustainable Development

23. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients

Weerkamp F., Dekking E., NG Y. Y., van der Velden V. H. J., Wai H., Boettcher S., et al.
LEUKEMIA , vol.23, no.6, pp.1106-1117, 2009 (SCI-Expanded, Scopus) Sustainable Development

24. Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?

Staal F. J. T., Pike-Overzet K., NG Y. Y., van Dongen J. J. M.
LEUKEMIA , vol.22, no.10, pp.1849-1852, 2008 (SCI-Expanded, Scopus) Sustainable Development

25. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity

NG Y. Y., van Kessel B., Lokhorst H., Baert M., van den Burg C., Bloem A., et al.
JOURNAL OF LEUKOCYTE BIOLOGY , vol.75, no.2, pp.314-323, 2004 (SCI-Expanded, Scopus) Sustainable Development

26. Selective in vitro expansion and efficient retroviral transduction of human CD34+ CD38- haematopoietic stem cells

NG Y. Y., Bloem A., van Kessel B., Lokhorst H., Logtenberg T., Staal F.
BRITISH JOURNAL OF HAEMATOLOGY , vol.117, no.1, pp.226-237, 2002 (SCI-Expanded, Scopus) Sustainable Development

27. Contaminants from the transplant contribute to intimal hyperplasia associated with microvascular endothelial cell seeding

Arts C., Joosten P., Blankensteijn J., Staal F., Ng P., Heijnen-Snyder G., et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY , vol.23, no.1, pp.29-38, 2002 (SCI-Expanded, Scopus) Sustainable Development

28. Frape-1 and Frape-3: Two different recombinant retroviruses encoding the same human marker gene

NG Y. Y., Veenhuizen P., Lokhorst H., Staal F.
CANCER GENE THERAPY , vol.7, no.4, pp.624-628, 2000 (SCI-Expanded, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 3

1. Pathways associated with relapse and high risk in childhood acute lymphoblastic leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., İşlek B., Fırtına S., CELKAN T. T., ANAK S. S., et al.
Europian Human Genetics Conference 2015, 6 - 09 June 2015, (Full Text)

2. Detection of CD19 ICOS TACI gene mutations in Turkish CVID patients

Sİnem Ş., Ayça K., Safa B., AYDINER E., Serdar N., HATIRNAZ NG Ö., et al.
4th European Congress of Immunology, 6 - 09 September 2015, (Summary Text)

3. Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
55th American Society of Hematology (ASH) Meeting, 7 - 10 November 2013, (Summary Text)
Books 1

1. Chapter 2 Isolation of Human and Moue Hematopoietic Stem Cells

NG Y. Y., Baert M., de Haas E., Pike Overzet K., Staal F.
in: Genetic Modification of Hematopoietic Stem Cells Methods and Protocols, Christopher Baum, Editor, Humana Press, pp.13-21, 2009
Metrics

Publication

32

Publication (WoS)

24

Publication (Scopus)

24

Citation (WoS)

388

H-Index (WoS)

10

Citation (Scopus)

442

H-Index (Scopus)

11

Citation (Scholar)

6

H-Index (Scholar)

1
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING